BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33792091)

  • 1. The effects and mechanisms of aloe-emodin on reversing adriamycin-induced resistance of MCF-7/ADR cells.
    Cheng G; Pi Z; Zhuang X; Zheng Z; Liu S; Liu Z; Song F
    Phytother Res; 2021 Jul; 35(7):3886-3897. PubMed ID: 33792091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Reversing effects of emodin on multidrug resistance in resistant HL-60/ADR cells].
    Chen YY; Li J; Hu JD; Zheng J; Zheng ZH; Zhu LF; Chen XJ; Lin ZX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1413-22. PubMed ID: 24370022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin.
    Zong L; Cheng G; Liu S; Pi Z; Liu Z; Song F
    J Pharm Biomed Anal; 2019 Feb; 165():268-275. PubMed ID: 30572191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal effects of nomegestrol acetate on multidrug resistance in adriamycin-resistant MCF7 breast cancer cell line.
    Li J; Xu LZ; He KL; Guo WJ; Zheng YH; Xia P; Chen Y
    Breast Cancer Res; 2001; 3(4):253-63. PubMed ID: 11434876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer.
    Zhang E; Liu J; Shi L; Guo X; Liang Z; Zuo J; Xu H; Wang H; Shu X; Huang S; Zhang S; Kang X; Zhen Y
    Life Sci; 2019 Dec; 238():116938. PubMed ID: 31593704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway.
    Yang L; Zhang C; Chen J; Zhang S; Pan G; Xin Y; Lin L; You Z
    Pharm Biol; 2020 Dec; 58(1):276-285. PubMed ID: 32251615
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reversal effect and its mechanism of (- )-5-N-acetylardeemin on adriamycin resistance in multidrug-resistant cancer cells A549/Adr and MCF-7/Adr].
    Zhao C; Zheng XL; Yan YY; Song H; Li DX; Yang L; Qin Y; Lin Y; Wang X; Liao LC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):893-7. PubMed ID: 25571710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
    Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
    Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barbigerone reverses multidrug resistance in breast MCF-7/ADR cells.
    Li X; Wan L; Wang F; Pei H; Zheng L; Wu W; Ye H; Wang Y; Chen L
    Phytother Res; 2018 Apr; 32(4):733-740. PubMed ID: 29368443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal effects of Rabdosia rubescens extract on multidrug resistance of MCF-7/Adr cells in vitro.
    Li F; Fan J; Wu Z; Liu RY; Guo L; Dong Z; Wang Z
    Pharm Biol; 2013 Sep; 51(9):1196-203. PubMed ID: 23777360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ophiobolin-O reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human breast carcinoma (MCF-7/ADR) cells.
    Sun W; Lv C; Zhu T; Yang X; Wei S; Sun J; Hong K; Zhu W; Huang C
    Mar Drugs; 2013 Nov; 11(11):4570-84. PubMed ID: 24240979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.
    Jiang J; Wang X; Cheng K; Zhao W; Hua Y; Xu C; Yang Z
    Mol Med Rep; 2016 Jun; 13(6):4745-50. PubMed ID: 27082231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal effects of two new milbemycin compounds on multidrug resistance in MCF-7/adr cells in vitro.
    Gao A; Liang H; Wang X; Zhang X; Jing M; Zhang J; Yan Y; Xiang W
    Eur J Pharmacol; 2011 Jun; 659(2-3):108-13. PubMed ID: 21458446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of ultrasound exposure on P-glycoprotein-mediated multidrug resistance in vitro and in vivo.
    Huang C; Huang S; Li H; Li X; Li B; Zhong L; Wang J; Zou M; He X; Zheng H; Si X; Liao W; Liao Y; Yang L; Bin J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):232. PubMed ID: 30231924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paris saponin VII reverses chemoresistance in breast MCF-7/ADR cells.
    Li Y; Sun Y; Tang T; Niu Y; Li X; Xie M; Jin H; Mei Q
    J Ethnopharmacol; 2019 Mar; 232():47-54. PubMed ID: 30552993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
    Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
    J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
    Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
    Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reversal effect of peptide-modified chitosan tetramethylpyrazine nanoparticles on multidrug resistance in tumor cells].
    Xiang-Yang L; Qing F; Chen-Yang Z; Ming-Kun S; Hui MA; Li-Chun C; Ren Bao Li Gao A; Zhen-Long YU
    Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(22):5487-5494. PubMed ID: 33350210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.